Compare General Mills, Inc. (GIS) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Mills, Inc. vs Repligen Corporation Common Stock — how do they compare? General Mills, Inc. trades at $32.25 (market cap $17.02B), while Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B). The key difference: General Mills, Inc. is the larger of the two by market cap, and General Mills, Inc. pays a 7.67% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Mills, Inc. for 107 Days and Repligen Corporation Common Stock for 0 Days on average.
| GIS | RGEN | |
|---|---|---|
Market Cap | $17.02B | $11.14B |
Volume | 7,979,067 | 1,259,263 |
Sector | Consumer Staples | Health |
52-Week High | $49.18 | $194.57 |
52-Week Low | $31.67 | $102.87 |
Typical Hold Time | 107 Days | 0 Days |
Enterprise Value | $30.20B | $11.02B |
Dividend Yield | 7.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Mills (GIS) trades at $32.11, down 1.8% on the day, reflecting recent pressure from a Q4 2025 earnings miss and a projected net loss for 2026. The stock shows a bearish technical trend, with key support at $32. Despite a low P/E of 9.23, profitability metrics like a negative ROE of -10.55% and a forecasted negative net income margin for 2026 highlight significant challenges. Recent news includes a CEO transition and a reaffirmed $0.61 quarterly dividend, but investor sentiment remains cautious amid declining revenues and margin pressures.
The outlook for GIS is clouded by execution risks in its turnaround strategy and macroeconomic headwinds. The high dividend yield offers income appeal, but the potential for a dividend cut and sustained earnings weakness presents substantial risk. Analyst consensus is predominantly Hold, with a $36 price target suggesting limited near-term upside, making the stock a speculative hold for income-focused investors tolerant of high risk.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
